Financials

	2021	2022
Net sales	-	-
Net income	-3.66Cr -2.63Cr -2.28Cr -2.13Cr -1.94Cr -250.53Cr -3.72Cr -25Cr -9.79Cr -125.4Cr -9.86Cr -9.65Cr -418.34Cr	-3.8Cr -2.73Cr -2.36Cr -2.21Cr -2.02Cr -260.13Cr -3.86Cr -26Cr -10Cr -130.2Cr -10Cr -10Cr -434.37Cr
Net Debt	-1.9Cr -1.36Cr -1.18Cr -1.1Cr -1.01Cr -129.83Cr -1.93Cr -13Cr -5.07Cr -65Cr -5.11Cr -5Cr -216.8Cr	76.74L 55.09L 47.74L 44.69L 40.78L 53Cr 78.03L 5.24Cr 2.05Cr 26Cr 2.07Cr 2.02Cr 88Cr

Company Profile

IMV Inc. is a Canada-based company. The Company has sold all of its assets. It is not engaged in any business operations.

Employees

Sector

Date	Price	Change	Volume
07/26/07	$0.000001	-99.00%	291
04/26/04	$0.000100	+9,900.00%	8,417

Real-time OTC Markets

Market Closed - OTC Markets 01:00:04 06/06/2025 am IST			5-day change	1st Jan Change
0.000100 ^USD	-.--%		-.--%	+9,900.00%

24/24/24	OPEC excited about Namibia partnership, offers support	RE
16/23/16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023

24/24/24	OPEC excited about Namibia partnership, offers support	RE
16/23/16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
11/22/11	IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
11/22/11	IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
29/22/29	IMV Inc. - Shareholder/Analyst Call

04/23/04	IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	AQ
14/19/14	IMV Inc. : to Present at Two Upcoming Investor Conferences	BU
12/19/12	Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	BU

Manager	Title	Age	Since
Stéphane Fiset CTO	Chief Tech/Sci/R&D Officer	-	-
Tracy Sherren SEC	Corporate Secretary	60	-
Marie-Eve Charrois LAW	General Counsel	-	-

Director	Title	Age	Since
Markus Warmuth BRD	Director/Board Member	55	06/11/2018
Michael Bailey CHM	Chairman	60	01/05/2022
Michael Kalos BRD	Director/Board Member	64	11/05/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/04/23	Shabnam Kazmi	Option	Director	48,259	0.4121%
06/04/23	Michael Kalos	Option	Director	52,378	0.4472%
06/04/23	Markus Warmuth	Option	Director	56,007	0.4782%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMV INC.	-.--%	-.--%	+9,900.00%	-99.76%	14
CHURCHILL CAPITAL CORP XI	+1.68%	+6.30%	-	-	91Cr
CENTIEL AG	+3.36%	-0.29%	+309.70%	-71.11%	66Cr
CHURCHILL CAPITAL CORP XII	+0.08%	+0.75%	-	-	60Cr
BAIN CAPITAL GSS INVESTMENT CORP.	+0.38%	+0.39%	-	-	60Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+1.13%	+1.48%	-	-	58Cr
NEW AMERICA ACQUISITION I CORP.	-0.00%	+0.30%	-	-	51Cr
CHURCHILL CAPITAL CORP XIII	-0.14%	-0.71%	-	-	50Cr
ARES ACQUISITION CORPORATION III	0.00%	+0.04%	-	-	49Cr
Average	+0.59%	+1.16%	+5,104.85%	-85.43%	53.87Cr
Weighted average by Cap.	+0.78%	+1.72%	+309.70%	-71.11%